Anupam Rasayan India Limited has disclosed the creation of a pledge on promoter shares under SEBI Takeover Regulations. Promoter Mona Anandbhai Desai pledged 19,80,000 equity shares to Aditya Birla Capital Limited for loan purposes, with the pledge created on December 29, 2025.

Pledge Transaction Details

The disclosure was made on January 2, 2026, to both BSE Limited and National Stock Exchange of India Limited under Regulation 31(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The pledge represents a significant encumbrance on the promoter's shareholding.

Promoter Shareholding Position

Mona Anandbhai Desai holds a total of 41,40,625 shares in the company, representing 3.64% of the total share capital. Prior to this transaction, the promoter had already pledged 7,00,000 shares, constituting 0.61% of the share capital.

Other Promoter Holdings

The disclosure also provides details of other promoters and their shareholding positions. Anand Sureshbhai Desai holds the largest stake among promoters with 1,10,76,940 shares representing 9.73% of share capital, with 80,75,000 shares already pledged. Kiran Pallavi Investments LLC holds the highest shareholding with 3,62,06,896 shares constituting 31.80% of the company's share capital, with no encumbrances.

Regulatory Compliance

The pledge creation has been duly reported to the stock exchanges where the company's shares are listed. The disclosure ensures transparency and compliance with SEBI regulations regarding substantial acquisition of shares and takeovers. The company maintains its listing on both BSE Limited and National Stock Exchange of India Limited.

Anupam Rasayan India Ltd has provided comprehensive details about its strategic acquisition of Jayhawk Fine Chemicals during an investor conference call, revealing the transaction structure and integration plans for the USD 150 million deal.

Acquisition Structure and Financial Details

The company has structured the acquisition through a balanced funding approach, with Anupam Rasayan investing USD 40 million through a combination of internal accruals and debt. The remaining USD 110 million is being invested by a leading global investment management firm through Class B non-voting shares, enabling full consolidation of Jayhawk's operations.

Strategic Rationale and Business Integration

Managing Director Anand Desai outlined five key strategic benefits of the acquisition. The deal establishes onshore manufacturing presence in the United States, significantly enhancing engagement with multinational customers who value geographical diversification and supply chain resilience. The acquisition expands Anupam's performance materials portfolio, particularly in high-value di-anhydrides and polyimide intermediates with applications in semiconductors, aviation, and electronics.

Jayhawk's Operational Profile

Jayhawk Fine Chemicals reported approximately USD 78 million revenue with EBITDA margins of around 19%. The revenue mix comprises 65% from performance materials and 35% from life science-related molecules, providing stability and growth visibility. The US facility spans nearly three million square meters with two manufacturing units and a pilot plant.

Combined Entity Projections

On a pro-forma basis, the combined entity would have revenues of approximately USD 243 million and EBITDA of approximately USD 61 million. CEO Gopal Agrawal indicated that the acquisition is expected to be EPS-accretive from day one, with the transaction scheduled to close in the second half of January.

Integration Strategy and Growth Plans

The company plans to create a powerful dual-site production model, combining Jayhawk's high-priority technology and advanced operations with Anupam's cost-efficient, backward-integrated manufacturing base in India. This synergy will offer global customers flexibility of localized US production and a highly integrated supply chain.

The management emphasized that existing Jayhawk operations will continue as-is initially, with selective capacity expansion planned based on customer requirements. The facility has significant expansion potential, with current manufacturing setup occupying only 15-20% of the available land.

The successful completion of this acquisition positions Anupam Rasayan as an integrated global specialty chemicals and CDMO platform, leveraging multi-geographic execution capabilities and strengthened customer relationships across high-growth end markets.